This approach involves removing T cells from the patient's blood, genetically modifying them to recognize cancer cells, and then reinfusing them back into the patient.
This approach involves removing T cells from the patient's blood, genetically modifying them to recognize cancer cells, and then reinfusing them back into the patient.